Women with Hypoactive Sexual Desire Disorder responded well to a skin patch containing testosterone, according to a late-stage clinical trial of 562 women whose sexual desire and activity had waned after menopause caused by removal of both ovaries.P&G said women receiving the testosterone patch had a 74 percent increase in frequency of "satisfying sexual activity" and a 56 percent increase in sexual desire, compared with the period before they received the patches.
The study was conducted at The Womens Health Research Center and 51 other centers in the U.S., Canada and Australia and preliminary results were presented during the 52nd Annual Clinical Meeting of The American College of Obstetricians and Gynecologists (ACOG).